AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-92072804/sicor-announces-tentative-anda.html" title="Facts and information about Sicor announces tentative ANDA approval for carboplatin injection.(abbreviated new drug application)(Brief Article)">Sicor announces tentative ANDA approval for carboplatin injection.(abbreviated new drug application)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Women's Health Weekly are available.
Frequently asked questions about RSS feeds
Sicor announces tentative ANDA approval for carboplatin injection.(abbreviated new drug application)(Brief Article)
2002 OCT 3 - (NewsRx.com & NewsRx.net) -- Sicor Inc., (SCRI) announced that the Food and Drug Administration (FDA) has tentatively approved an abbreviated new drug application (ANDA) by its wholly owned subsidiary, Gensia Sicor Pharmaceuticals, Inc., for Carboplatin Injection.
Carboplatin is indicated for the treatment of patients with ovarian cancer. Gensia Sicor's carboplatin product is a liquid ready-to-use formulation packaged in a shatter resistant polymer vial.
Based on ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Mayne Pharma (USA) Inc. Adds Carboplatin Injection to its Product Line.
- Press release article from: PR Newswire October 14, 2004 700+ words
...s Abbreviated New Drug Application for Carboplatin Injection. Stuart Hinchen...the US market and Carboplatin injection is another important...Pharma will be making Carboplatin Injection available in 50mg...
- Mayne Pharma (USA) Inc adds carboplatin injection to its product line.
- News wire article from: Asia Africa Intelligence Wire October 14, 2004 700+ words
...approval for the company's Abbreviated New Drug Application for Carboplatin Injection incorporating Onco-Tain technology...agents. Mayne Pharma will be making Carboplatin Injection available in 50 mg/5 ml, 150 mg...
- Spectrum Pharmaceuticals Receives FDA Approval for Carboplatin Injection ANDA.
- Press release article from: PR Newswire June 14, 2005 700+ words
...Administration (FDA) for the Abbreviated New Drug Application (ANDA) for carboplatin injection in 50 mg, 150 mg and 450 mg multi...for the marketing and distribution of carboplatin injection in the United States. With extensive...
- American Pharmaceutical Partners Receives Approval for Carboplatin Injection.
- Press release article from: PR Newswire October 21, 2004 700+ words
...received approval from the U.S. Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) of Carboplatin Injection (liquid form), the generic equivalent of Bristol-Myers Squibb Company's Paraplatin(R...
- Spectrum Pharmaceuticals receives FDA approval for carboplatin injection ANDA.
- News wire article from: Asia Africa Intelligence Wire June 14, 2005 700+ words
...Office of Generic Drugs of the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) for carboplatin injection in 50 mg, 150 mg and 450 mg multi-dose vials. Carboplatin is a platinum-based, anti...
- American Pharmaceutical Partners receives approval for carboplatin injection.
- News wire article from: Asia Africa Intelligence Wire October 21, 2004 700+ words
...has received approval from the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA) of Carboplatin Injection (liquid form), the generic equivalent of Bristol-Myers Squibb company's Paraplatin. APP...
- American Pharmaceutical Partners receives FDA Approval for Carboplatin...
- News wire article from: Chemical Business Newsbase February 17, 2006 700+ words
...has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Carboplatin Injection (liquid form) in a 600 mg multi-dose vial. Combined sales of the 600 mg dosage form by all...
- American Pharmaceutical Partners Receives FDA Approval for Carboplatin...
- Press release article from: PR Newswire February 17, 2006 700+ words
...received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Carboplatin Injection (liquid form) in a 600 mg multi-dose vial. Carboplatin is the generic equivalent of Bristol...
- Teva Announces Tentative Approval of Carboplatin Injection.
- Press release article from: Business Wire January 15, 2003 700+ words
...and Drug Administration has granted tentative approval for the company's ANDA for Carboplatin Injection, 50 mg, 150 mg, and 450 mg. Carboplatin Injection is the generic equivalent of Bristol-Myers Squibb's Paraplatin(R). The product...
- Teva announces tentative approval of Carboplatin injection.
- News wire article from: Asia Africa Intelligence Wire January 15, 2003 700+ words
...has granted tentative approval for Teva Pharmaceutical Industries Ltd's ANDA for Carboplatin Injection, 50 mg, 150 mg, and 450 mg. Carboplatin Injection is the generic equivalent of Bristol-Myers Squibb's Paraplatin. The product...
Source: HighBeam Research, Sicor announces tentative ANDA approval for carboplatin...